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ABSTRACT 
The membrane-permeabilizing activities of mastoparans and related histamine-releasing 
agents were compared through measurements of K+ efflux from bacteria, erythrocytes, and 
mast cells.  Changes in bacterial cell viability, hemolysis, and histamine release, as well as 
in the shape of erythrocytes were also investigated.  The compounds tested were 
mastoparans (HR1, a mastoparan from Polistes jadwagae, and a mastoparan from Vespula 
lewisii), granuliberin R, mast cell-degranulating peptide, and compound 48/80, as well as 
antimicrobial peptides, such as magainin I, magainin II, gramicidin S, and melittin.  We used 
a K+-selective electrode to determine changes in the permeability to K+ of the cytoplasmic 
membranes of cells.  Consistent with the surface of mast cells becoming negatively charged 
during histamine release, due to the translocation of phosphatidylserine to the outer leaflet of 
the cytoplasmic membrane, histamine-releasing agents induced K+ efflux from mast cells, 
dependent on their ability to increase the permeability of bacterial cytoplasmic membranes 
rich in negatively charged phospholipids.  The present results demonstrated that amphiphilic 
peptides, possessing both histamine-releasing and antimicrobial capabilities, induced the 
permeabilization of the cytoplasmic membranes of not only bacteria but mast cells.  
Mastoparans increased the permeability of membranes in human erythrocytes at higher 
concentrations, and changed the normal discoid shape to a crenated form.  The structural 
requirement for making the crenated form was determined using compound 48/80 and its 
constituents (monomer, dimer, and trimer), changing systematically the number of cationic 
charges of the molecules.    
 
Keywords: Mastoparan; Compound 48/80; Amphiphilic peptide; Antimicrobial peptide; 
Histamine-releasing agent; Membrane permeability; Cell shape 
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1. Introduction 
 
Amphiphilic peptides can interact with membrane phospholipids, independently of 
specific receptors, in a rapid and concentration-dependent way [1−9].  These peptides 
generally form a cationic amphiphilic secondary structure, with hydrophobic and cationic 
amino acid residues in opposite directions, and therefore, can interact with membrane lipids 
through both electrostatic and hydrophobic interactions.  The bacterial cytoplasmic 
membrane presents an outermost leaflet rich in negatively charged phospholipids, while the 
external face of mammalian cells is predominantly composed of zwitterionic phospholipids.  
Besides the zwitterionic lipids, the mammalian cells have high concentrations of cholesterol, 
which acts to stabilize the bilayer.  The lipid composition of the cell membrane has been 
shown to be of paramount importance to the selectivity of the permeabilization activity.  An 
important feature of amphiphilic peptides showing antimicrobial activity is positively charged 
residues distributed along the peptide chain, serving to generate an amphiphilic structure.  
The presence of these charged groups generally renders the peptide more active against 
bacteria.  Moreover, due to weak interaction with zwitterionic lipids and cholesterol, most of 
the peptides act weakly on mammalian cells. 
In the present study, we were particularly interested in the influences of mastoparans 
and related histamine-releasing reagents on the permeability of the cytoplasmic membrane of 
mast cells, compared with the membranes of bacterial cells and erythrocytes.  Mastoparans 
and many cationic substances activate rat peritoneal mast cells, leading to the rapid release of 
histamine by exocytosis [10−12].  These agents trigger mast cell exocytosis by directly 
activating G proteins that control exocytosis [13−16], and hence, the secretion of histamine 
generally proceeds without changes to the permeability of the plasma membrane of mast cells.  
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In secretory cells, however, the transbilayer movement of an anionic phospholipid from the 
inner to outer leaflet of the plasma membrane is known to occur during platelet activation and 
exocytotic release from mast cells [17−19].  Thus, it was speculated that mastoparans, which 
act weakly on mammalian cells but strongly on bacterial cells, may enhance permeabilization 
in mast cells, because the surface of mast cells becomes negatively charged during histamine 
release, due to the translocation of phosphatidylserine to the outer leaflet of the cytoplasmic 
membrane [19].   
To clarify the actions of amphiphilic peptides in terms of cell membrane dependence in 
detail, we compared the membrane-permeabilizing activities of various mast 
cell-degranulating peptides and antimicrobial peptides using three different types of cells; rat 
peritoneal mast cells, human erythrocytes, and Staphylococcus aureus cells.  The 
compounds tested included mastoparans (such as HR1 from the giant hornet Vespa orientalis 
[20], mastoparan from Polistes jadwagae [11], and mastoparan from Vespula lewisii 
[10,11,21]), granuliberin R [22], mast cell-degranulating peptide [23], and a synthetic 
histamine liberator, compound 48/80 [24,25], as well as antimicrobial peptides, such as 
magainin I [26], magainin II [26], gramicidin S [27−29], and melittin [28,29].  The 
sequences of peptides and the structure of compound 48/80 and its constituents are shown in 
Table 1 and Fig. 1, respectively.  They all possess a cationic amphiphilic structure.  We 
used a K+-selective electrode to monitor changes in the permeability of the cytoplasmic 
membrane of cells.  Because the internal ionic environment of bacterial and mammalian 
cells is generally rich in K+, leakage of this ion has been used to monitor membranolytic 
events in various cell systems [21,27,29,30].  We present here for the first time evidence that 
amphiphilic peptides, possessing both histamine-releasing and antimicrobial capabilities, 
enhanced the permeability to K+ of not only bacteria but mast cells. 
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   Although mastoparans, like many amphiphilic peptides tested in this study, acted weakly 
on erythrocyte membranes, we were particularly interested in the morphological changes of 
human erythrocytes induced by the peptides, having previously observed that amphiphilic 
peptides, melittin and gramicidin S, caused changes in the normal discoid shape of human 
erythrocytes to produce a crenated form at the concentrations causing the change in 
permeability [29].  Such a direct observation of morphological change seemed to provide 
significant information on the mechanism of action of amphiphilic compounds.  The 
barrel-stave and carpet models have been proposed to explain the permeabilization of 
membranes by amphiphilic peptides [1−8].  In the barrel-stave model, peptide monomers 
associate and form a bundle of helices embedded in the membrane, forming a transmembrane 
channel.  In the carpet-like model, the peptides cover the membrane like a carpet and remain 
there with their hydrophobic surface facing the membrane and their hydrophilic surface 
facing the solvent.  According to this model, the bilayer is destroyed by the formation of 
toroidal pores, micelles, and vesicles.  After the treatment of human erythrocytes with 
mastoparans, changes from a normal discoid to crenated form were observed, showing the 
accumulation of the peptides at the outer surface of the membrane.  This finding supported 
that mastoparans increased the permeability of the erythrocyte membrane as proposed by the 
carpet model [4,31].  The structural requirement for making the crenated form was further 
investigated with the use of compound 48/80 and its constituents (monomer, dimer, and 
trimer) [32], changing systematically the number of cationic charges of the molecules.  
Compound 48/80 is a polycationic polymer prepared by condensation of 
p-methoxy-N-methylphenethylamine and formaldehyde, and the most active polymer is the 
hexamer [24,25], as shown in Fig. 1. 
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2. Materials and methods 
 
2.1. Reagents 
     The sources of reagents were as follows: mastoparan HR1 (named mast 
cell-degranulating peptide HR1 in the Sigma catalog), mastoparan from Polistes jadwagae 
(hereafter, Polistes mastoparan), mast cell-degranulating peptide (MCD peptide), granuliberin 
R, gramicidin S, melittin, magainin I, magainin II, compound 48/80, and valinomycin from 
Sigma (St. Louis, MO); mastoparan from Vespula lewisii (Vespula mastoparan) from Peptide 
Institute (Osaka, Japan); dioctyl phthalate from Tokyo Kasei (Tokyo, Japan); and poly(vinyl 
chloride) (PVC) (degree of polymerization, 1020) from Nacalai Tesque (Kyoto, Japan).  The 
monomer, dimer, and trimer of compound 48/80 were prepared as reported previously [32].  
All other materials were of analytical reagent grade.  
 
2.2. Electrode system 
     The K+-selective electrode was constructed using a PVC-based membrane as reported 
previously [30,33].  The PVC membrane had the following composition: 1 mg of 
valinomycin, 60 μl (about 60 mg) of dioctyl phthalate, and 30 mg of PVC.  The materials 
were dissolved in tetrahydrofuran (about 1 ml) and poured into a flat Petri dish (28 mm in 
diameter).  Then, the solvent was evaporated off at room temperature.  The resulting 
membrane was excised and attached to a PVC tube (4 mm in outer diameter and 3 mm in 
inner diameter) with tetrahydrofuran adhesive.  The PVC tube was filled with 10 mM KCl, 
and the sensor membrane was conditioned overnight.  The electrochemical arrangement was 
Ag,AgCl/10 mM KCl/sensor membrane/sample solution/1 M NH4NO3 (salt bridge)/10 mM 
KCl/Ag,AgCl.  The electromotive force (emf) between the silver/silver chloride electrodes 
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was measured using a voltmeter with high input impedance produced by a field-effect 
transistor operational amplifier (LF356, National Semiconductor, Sunnyvale, CA; input 
resistance >1012 Ω) and was recorded.  
 
2.3. Bacteria and erythrocytes 
     S. aureus FDA 209P cells were grown at 37oC in a medium containing 1.5% 
polypeptone, 0.5% bovine extract, 0.5% NaCl, and 0.5% K2HPO4 [27].  The cells were 
harvested in an exponential phase of growth, washed twice with buffer (100 mM choline 
chloride and 50 mM 4-morpholinepropanesulphonic acid (Mops)−Tris, pH 7.2), and 
suspended in this buffer at 5 × 109 cells/ml (0.6 mg cell protein/ml).  Protein content was 
determined by the method of Lowry et al. [34].  Human erythrocytes were suspended in 0.15 
M NaCl and 5 mM 4-(2-hydroxyethyl)-1-peperazineethanesulphonic acid (Hepes)−NaOH 
(pH 7.4) at 1% hematocrit of 1 × 108 cells/ml.  Cells were incubated with reagent at 37oC for 
30 min, and the amount of K+ effluxed was measured with a K+-selective electrode [29].  
The total amount of K+ was determined by disrupting cells with melittin [29].  The viability 
of cells was determined by counting colonies, and hemolysis was estimated by measuring the 
absorbance at 540 nm [29]. 
 
2.4. Mast cells 
     Mast cells were collected from the peritoneal cavities of male Wistar rats (300−350 g) 
and purified using Percoll as reported previously [35].  The mast cells were suspended in a 
K+-free buffer comprising 0.154 M NaCl, 0.9 mM CaCl2, 5.6 mM glucose, 0.01% bovine 
serum albumin, and 5 mM Hepes−NaOH (pH 7.4) at 8 × 105 cells/ml.  Because a great deal 
of spontaneous efflux of K+ was observed at 37oC, this experiment was carried out at a lower 
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temperature, 20oC.  We monitored the time course of the efflux from mast cells in situ to 
avoid any experimental error arising from a spontaneous efflux, minimizing the difference in 
electric potential of the K+-selective electrode before and after addition of the reagent.  
Furthermore, we measured the efflux of K+ from mast cells by increasing the cell 
concentration to 8 × 105 cells/ml, using a miniaturized measuring system.  This made the 
results more reliable, compared with a previous study [21].  Specifically, the K+ and 
histamine assays proceeded as follows.  The K+ and reference electrodes were immersed in a 
mast cell suspension (200 μl), and the suspension was constantly stirred with a stirrer bar.  
The electrode system was compact [30], and therefore, as little as 200 μl could be measured.  
After the change in potential resulting from K+ efflux was recorded for 5 min, 50 μl of the cell 
suspension was pipetted to analyze histamine release, and melittin (final concentration, 50 
μM) was added to the remaining cell suspension to determine the total amount of K+ in mast 
cells.  The amount of histamine was determined fluorometrically after conversion to the 
fluorescent product by a reaction with o-phthalaldehyde as reported [36].     
 
2.5. Morphological observations 
     Cells were fixed with 2% glutaraldehyde dissolved in 1/30 M NaH2PO4/Na2HPO4 (pH 
7.4) and observed under an optical microscope connected to a monitor [37,38].  Shape 
changes were quantified using the morphological indices defined by Fujii and co-workers 
[39]. 
 
3. Results 
 
3.1. K+ permeability measurements using mast cells  
     Permeability measurements using a K+-selective electrode are widely performed using 
 9
bacteria and erythrocytes, as well as artificial liposomes [27,29,30,33,40−43].  In this study, 
we applied the electrode to mast cells.  Because the difference in the electric potential of the 
K+-selective electrode before and after the addition of reagents was relatively small, we 
monitored the time course of the efflux of K+ from mast cells in situ.  Fig. 2a shows the 
calibration graph for the K+ electrode in a K+-free buffer comprising 0.154 M NaCl, 0.9 mM 
CaCl2, 5.6 mM glucose, 0.01% bovine serum albumin, and 5 mM Hepes−NaOH (pH 7.4).  
Fig. 2b shows the effect of HR1 on the efflux from mast cells.  Addition of the cell 
suspension produced an increase in the K+ concentration, which was attributed to the K+ 
remaining in the cell suspension.  Addition of HR1 (10 μM) induced an increase in the K+ 
concentration with a short time lag.  Finally, a high concentration of melittin (50 μM) was 
added to disrupt the membrane of mast cells, in order to determine the total amount of K+ 
contained in the cells.  Thus, it was calculated that HR1 (10 μM) induced 48% efflux within 
5 min from the calibration graph shown in Fig. 2a.  Such direct monitoring presented 
unambiguous evidence of the efflux of K+ from mast cells.  Furthermore, the fact that the 
efflux of K+ began to increase shortly after addition of HR1 correlated with the time-required 
release of histamine [44] accompanying the translocation of phosphatidylserine to the outer 
leaflet of the cytoplasmic membrane. 
 
3.2. K+ efflux, cell viability, hemolysis, and histamine release  
     Fig. 3 shows HR1-induced K+ efflux, cell viability, hemolysis, and histamine release in 
S. aureus cells, erythrocytes, and mast cells.  As shown in Fig. 3a, this peptide lowered the 
viability of S. aureus cells at the concentrations causing changes in permeability to K+, 
indicating that the antimicrobial activity of HR1 was the result of increased membrane 
permeability, as in the case of many antimicrobial peptides [1−9].  This peptide also caused 
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the efflux of K+ from erythrocytes and hemolysis at higher concentrations.  The weak 
activity against mammalian cells is a general characteristic of amphiphilic peptides [1−9].  
An interesting feature is that the concentrations required for the efflux from mast cells were 
significantly lower than those used with erythrocytes.  This is most probably because the 
surface of mast cells became negatively charged during the secretion of histamine, due to the 
translocation of phosphatidylserine to the outer leaflet of the cytoplasmic membrane of mast 
cells [19], making the peptide susceptible to mast cells, as mentioned in the Introduction.  
Furthermore, HR1 induced K+ efflux from mast cells immediately after liberating histamine.  
This indicated that HR1 had the ability to interact with negatively charged lipids on mast cells, 
in accordance with the strong effect on bacterial membranes rich in anionic lipids, as shown 
in Fig. 3a.  Similar results were obtained with Polistes mastoparan and Vespula mastoparan.  
Table 2 summarizes ED50 values (concentrations giving 50% K+ efflux, cell viability, 
hemolysis, or histamine release) for these mastoparan groups, along with the results for 
related histamine-releasing agents mentioned later.  
Next, we examined the effects of granuliberin R (Fig. 4).  This peptide, isolated from 
frog skin, has been reported to liberate histamine from rat peritoneal mast cells [22], though 
no study has reported antimicrobial activity.  In fact, granuliberin acted very weakly on S. 
aureus cells, while it induced the release of histamine from mast cells near the concentration 
range of HR1.  No remarkable K+ efflux from erythrocytes or hemolysis was observed.  
Interestingly, the efflux from mast cells occurred close to the concentration range causing K+ 
efflux from S. aureus cells, though at very high concentrations.  This finding seemed to 
support the view that the peptide acted on anionic lipids of not only bacterial cells but mast 
cells that appeared during histamine secretion, though the concentrations needed to 
permeabilize membranes were very high.  MCD peptide [23], a potent histamine liberator 
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found in bee venom, did not remarkably induce K+ efflux from mast cells, consistent with the 
absence of antimicrobial activity at the concentrations tested.  The ED50 values (the 
concentrations giving 50% K+ efflux, cell viability, hemolysis, and histamine release) for 
granuliberin R and MCD peptide are summarized in Table 2. 
     Fig. 5 shows the results for compound 48/80.  This compound is known to effectively 
liberate histamine via a selective and noncytotoxic action [45], and also to act as a weak 
antimicrobial agent [46,47].  Consistent with this, it effectively liberated histamine from 
mast cells at low concentrations, and reduced the viability of S. aureus cells at relatively high 
concentrations.  Compound 48/80 decreased the viability of S. aureus cells concomitantly 
with the efflux of K+, showing that the antimicrobial activity was attributable to the increased 
permeability of the bacterial cytoplasmic membrane.  The efflux from mast cells was 
induced at a much lower concentration range than that from erythrocytes, and rather near to 
the concentrations required for K+ efflux from S. aureus cells, also indicating the 
susceptibility of the histamine-releasing agent to negatively charged membranes. 
     The same experiments were performed using various membrane-active peptides; 
magainin I, magainin II, gramicidin S, and melittin.  Table 2 summarizes ED50 values for all 
substances tested in this study.  In general, there was a tendency for the amphiphilic peptides, 
with both histamine-releasing and antimicrobial capabilities, to induce the permeabilization of 
the cytoplasmic membranes of not only bacteria but mast cells.            
 
3.3. Morphological changes in human erythrocytes 
Fig. 6 shows mastoparan-induced morphological changes in human erythrocytes at the 
concentrations causing hemolysis (about 20−30%).  All the mastoparans caused a change 
from the normal discoid shape to a crenated form, as in the case of gramicidin S and melittin 
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reported previously [29].  The crenated cells increased with increasing concentrations of the 
peptides.   
Changes in the shape of human erythrocytes induced by amphiphilic compounds are 
generally discussed based on the bilayer couple hypothesis proposed by Sheetz and Singer 
[48].  According to this hypothesis, cell shape is strongly dependent on the charge of the 
amphiphiles.  Negatively charged amphiphiles caused discoid cells to adopt a crenated form 
named echinocytes, while positively charged amphiphiles with proper lipophilicity generated 
an invaginated form named stomatocytes.  Anionic amphiphiles that produce echinocytes 
associated mostly with the outer monolayer of the erythrocyte membrane, as a result of their 
inability to cross the bilayer, or because of repulsion by a negatively charged 
phosphatidylserine located in the inner monolayer of the erythrocyte membrane [49].  
Conversely, cationic amphiphiles that induced stomatocytes did so by partitioning selectively 
into the cell inner monolayer, through association with an inner anionic lipid.  However, the 
cationic compounds, whose rates of transmembrane movement were slow, made the 
erythrocytes crenated [39,50].  The mastoparans tested in this study changed the shape to 
that of echinocytes.  These peptides had several basic amino acids, such as lysine, and also 
acidic amino acid, such as aspartic acid, in Polistes mastoparan, making it strongly 
hydrophilic, and hence, they had difficultly crossing the lipid interior, causing selective 
accumulation in the outer monolayer, leading to the formation of echinocytes.  To obtain 
further insight into the dependence of changes in cell shape on the number of cationic charges, 
we used compound 48/80 and its components (monomer, dimer, and trimer).  Dialysis and 
gel filtration [24] and NMR studies [25] have shown that the most active polymer is probably 
the hexamer.  Fig. 7 shows the morphological change of human erythrocytes induced by 
compound 48/80 and its components, at the same concentration (0.2 mg/ml).  The monomer 
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did not induce marked changes in morphology at this concentration, probably due to low 
partition in membranes.  The dimer caused a change to the invaginated form, indicating that 
it was preferentially incorporated into the inner monolayer of the membrane by interacting 
with an inner anionic phospholipid, because it was more lipophilic than the monomer.  
However, the trimer suppressed the change to the invaginated form, and moreover, 48/80 
induced echinocytes to form.  These results indicated that the increased number of cationic 
charges producing a strong hydrophilic nature made it difficult for the compounds to traverse 
the lipid interior.  We expressed the dose-dependence of the change in shape using 
morphological indices defined by Fujii and co-workers [39].  As shown in Fig. 8, the dimer 
induced changes to the higher stages of the invaginated form with increases in the 
concentration, while the trimer suppressed a change in the invaginated form, and 48/80 
induced morphological change in the opposite direction, making echinocytes.  Compound 
48/80 induced hemolysis (about 20%) at a concentration of 0.2 mg/ml.  This feature was 
similar to mastoparans, inducing hemolysis via echinocytes. 
 
4. Discussion 
 
     In this study, we made potentiometric measurements with a K+-selective electrode to 
analyze the actions of cationic amphiphilic compounds on S. aureus cells, erythrocytes, and 
mast cells.  The use of an ion-selective electrode for biochemical analysis is attractive, 
because the measurement is fast, easy, and continuous in a turbid cell suspension.  Hence, 
ion-selective electrodes have widely been applied to the assay of membrane permeability 
[27,29,30,33,40−43].  For analyzing changes in the permeability of cytoplasmic membranes 
of living cells, the use of a K+-selective electrode is quite effective, because K+ is present in 
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the cytoplasm of all kinds of cells, and the permeability-increasing action of biologically 
active substances in different cells can be easily compared.  A drawback is the relatively low 
sensitivity of the electrodes which requires a high concentration of cells.  With bacteria and 
erythrocytes, it is easy to prepare a large number of cells; however, for mast cells, preparing 
large numbers is rather difficult.  We solved this problem by using small volumes of cell 
suspension (200 μl) to enhance the concentration of cells.  This made it possible to perform 
5−6 measurements from 106 mast cells, which could usually be collected from the abdominal 
cavity of an individual rat. 
     Mastoparans generally exhibit low hemolytic activity, but relatively high antimicrobial 
activity [21].  All the mastoparans tested in this study (HR1, Polistes mastoparan, and 
Vespula mastoparan) gave just such results.  Several characteristics of the peptides’ actions 
should be mentioned.  First, all mastoparans increased the permeability of S. aureus cells to 
K+, and decreased cell viability at similar concentrations, supporting that the antimicrobial 
activity of mastoparans was attributable to the increased permeability of the bacterial 
membrane.  Second, mastoparans were more effective in increasing the permeability of mast 
cells than erythrocytes.  Because the release of histamine eventually produced a negative 
charge in mast cells, the efflux of K+ from mast cells was observed after histamine’s secretion.  
Third, the finding that the concentrations required for the efflux of K+ from S. aureus cells 
were much lower than those needed for the release of histamine indicates that the 
mastoparans acted as antimicrobial agents rather than histamine liberators.  Antimicrobial 
peptides, magainin I and magainin II, acted on bacteria and mast cells, similarly to the 
mastoparans, though these peptides were less effective against erythrocyte membranes than 
mastoparans.  Peptides acting strongly against both bacteria and erythrocytes, such as 
melittin and gramicidin S, functioned at similar concentrations.  An interesting feature is that 
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mastoparans and magainins, whose antimicrobial activity was stronger than the 
histamine-releasing activity, increased K+ efflux from mast cells, near to the concentration 
causing histamine release.  This indicated that the membranolytic action of these peptides on 
mast cells was strong, because of the high affinity for anionic lipids.  Indeed, Vespula 
mastoparan has been reported to show a cytotoxic effect, due to the permeabilization of the 
plasma membrane of mast cells [51], similarly to melittin [52].  Granuliberin R and MCD 
peptide acted much more selectively as histamine liberators than the mastoparans and 
magainins.  These peptides could not interact with anionic lipids sufficiently to permeabilize 
the membrane, probably because the separation between the cationic and hydrophobic amino 
acid residues was insufficient to generate an effective amphiphilic structure in the molecules 
[53].  At high concentrations, however, granuliberin R induced K+ efflux from mast cells 
and bacterial cells, supporting the view that the peptide acted on anionic lipids of not only 
bacterial cells but mast cells during histamine secretion.  Interestingly, compound 48/80, a 
potentially active histamine liberator, is also a weak antimicrobial agent [46,47].  In fact, 
compound 48/80 induced histamine release at very low concentrations, while relatively high 
concentrations were required to induce the efflux of K+ from bacteria.  The concentration 
required for the efflux from mast cells was significantly lower than that needed for the efflux 
from bacteria.  This may be attributable to a difference in susceptibility to compound 48/80 
among anionic membranes in different environments, because the effects of amphiphilic 
compounds including 48/80 are known to differ among bacteria, despite the bacterial 
cytoplasmic membranes being generally rich in negatively charged lipids [5,26,47].  
Summarizing the present results, we showed for the first time that histamine-releasing agents, 
also possessing antimicrobial activity, caused the permeabilization of membranes in both 
bacteria and mast cells.  
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We further investigated the morphological changes to human erythrocytes induced by 
mastoparans.  All the mastoparans caused a change from the normal discoid shape to a 
crenated form (echinocytes) at the concentrations causing hemolysis.  In general, cationic 
amphiphilic compounds cause invaginated forms named stomatocytes, as a result of electric 
interaction with phosphatidylserine that is concentrated in the inner leaflet of the cytoplasmic 
membrane [49].  However, the hydrophilicity of cationic compounds is also known to induce 
the formation of echinocytes, because of the reduced permeability of the agents through the 
membrane interior [39,50].  There are several basic amino acids, such as lysine, and also 
acidic amino acid, such as aspartic acid, in Polistes mastoparan, making it strongly 
hydrophilic, and hence, the peptides predominantly accumulated in the outer monolayer of the 
erythrocyte membrane, forming echinocytes.  To obtain further insight into the dependence 
of cationic charges on cell shape, we used compound 48/80 and its components (monomer, 
dimer, and trimer).  The most active constituent of compound 48/80 is reported to be the 
hexamer.  Thus, the cationic charges of the monomer, dimer, trimer, and compound 48/80 
increased to +1, +2, +3, and +6, respectively.  The monomer did not induce marked changes 
in morphology, because of the low activity to permeate the membrane.  It is well established 
that appropriate hydrophobicity is required to induce changes of shape in erythrocytes [54,55].  
The dimer caused a change to an invaginated form.  Because the dimer was more lipophilic 
than the monomer, it could easily permeate the membrane, further traverse the lipid interior, 
and reach the inside of the membrane by interacting with anionic phospholipids that are 
concentrated in the inner half of the membrane.  The trimer suppressed the change to the 
invaginated form, and 48/80 generated echinocytes.  These results indicate that an increase 
in cationic charge, enhancing hydrophilicity, made it difficult to cross the lipid interior.  
Compound 48/80 caused hemolysis after the transformation of erythrocytes into echinocytes.  
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Melittin and gramicidin S have also been reported to generate echinocytes at the 
concentrations causing hemolysis [29].   
     Aside from the erythrocyte shape changes studied here, the effects of antimicrobial 
peptides on bacterial membranes have been studied extensively by electron microscopy.  
When magainin II was used at a concentration where bacterial viability had decreased about 
30%, blebs were observed on the surface of the bacteria [56].  Melittin also formed blebs on 
bacterial cells [57].  The formation of patches, structurally similar to blebs, is observed after 
treatment with various antimicrobial peptides [4,31].  The appearance of blebs or patches on 
bacterial membranes seemed to be similar to the change to echinocytes by human 
erythrocytes, as a result of the accumulation of peptides on the outer surface of the cell 
membranes.  Hence, these results demonstrated that the breakdown of the biological 
membranes including erythrocytes and bacteria proceeded as proposed by the carpet model 
[4,31], accompanied by the accumulation of agents at the outer surface.       
 
5. Conclusion 
 
In this study, histamine-releasing agents induced K+ efflux from mast cells, dependent 
on their ability to cause K+ efflux from bacteria.  The present results explained how the 
membrane permeabilization of mast cells by histamine-releasing agents correlated with their 
antimicrobial abilities.  Furthermore, we observed that mastoparans changed the normal 
discoid shape of human erythrocytes to a crenated form at the concentrations causing 
hemolysis.  An experiment using compound 48/80 and its components revealed that 
increasing the cationic charge changed the erythrocytes into echinocytes.  Such changes 
correlated with blebs or patches formed on bacterial membranes, as a result of the 
 18
accumulation of peptides at the outer surface of the cell membranes.  The present results 
supported that amphiphilic cationic peptides induced the breakdown of biological membranes 
including erythrocytes as proposed by the carpet model.       
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Table 1 
Peptides used.  
 
Peptide Sequencea 
HR1 I-N-L-K-A-I-A-A-L-V-K-K-V-L-NH2 
Polistes mastoparan V-D-W-K-K-I-G-Q-H-I-L-S-V-L-NH2 
Vespula mastoparan I-N-L-K-A-L-A-A-L-A-K-K-I-L-NH2 
Granuliberin R F-G-F-L-P-I-Y-R-R-P-A-S-NH2 
MCD peptide  I-K-C-N-C-K-R-H-V-I-K-P-H-I-C-R-K-I-C-G-K-N-NH2 
Magainin I G-I-G-K-F-L-H-S-A-G-K-F-G-K-A-F-V-G-E-I-M-K-S 
Magainin II G-I-G-K-F-L-H-S-A-K-K-F-G-K-A-F-V-G-E-I-M-N-S 
Melittin G-I-G-A-V-L-K-V-L-T-T-G-L-P-A-L-I-S-W-I-K-R-K-R-Q-Q-NH2 
Gramicidin S cyclo(VOLFdPVOLFdP) 
 
a Amino acids are labeled according to the one-letter code with the following additions: O = 
ornithine, Fd = D-phenylalanine.  Block letters indicate basic and acidic amino acids.  
Acidic amino acids, aspartic acid (D) and glutamic acid (E), contained in Polistes mastoparan 
and magainins, respectively.  Disulfide linkages are shown by solid lines.  
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Table 2 
ED50 values (concentrations giving 50% K+ efflux, cell viability, hemolysis and histamine 
release) of mastoparans and related histamine-releasing compounds. a   
 
  S. aureus cells Human erythrocytes 
Rat peritoneal mast 
cells 
  K+ efflux 
Cell 
viability 
K+ efflux Hemolysis K+ efflux 
Histamine 
release 
HR1 2 2 50 50−100 10 5 
Polistes mastoparan 5 5 50 100−200 10 2−5 
Vespula mastoparan 2−5 2−5 50 50−100 10−20 5−10 
Granuliberin R 500 500 >500 >500 200−500 10 
MCD peptide >50 >50 >200 >200 >50 0.05 
Compound 48/80 100 50−100 >500 >500 10−20 0.5 
Magainin I 10 10 >200 >200 20 10−20 
Magainin II 5−10 5−10 >200 >200 20 10−20 
Melittin 0.2−0.5 0.2−0.5 0.2−0.5 0.2−0.5 1−2 0.5 
Gramicidin S 2−5 2−5 10 10 20 10−20 
 
a ED50 values are shown in μM, except for compound 48/80 (μg/ml). 
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Figure Legends 
 
Fig. 1.  Structure of (a) compound 48/80 and its components; (b) monomer, (c) dimer, and 
(d) trimer.  
 
Fig. 2.  (a) Calibration graph for the K+-selective electrode in a K+-free buffer comprising 
0.154 M NaCl, 0.9 mM CaCl2, 5.6 mM glucose, 0.01% bovine serum albumin, and 5 mM 
Hepes−NaOH (pH 7.4).  (b) The efflux of K+ from mast cells induced by HR1.  The mast 
cell suspension (30 μl, final cell concentration of 8 × 105 cells/ml) was added to 170 μl of the 
K+-free buffer at 20oC at the time indicated by the first arrow.  The second arrow indicates 
when 1 μl of 2 mM HR1 (final concentration, 10 μM) was added.  The third arrow indicates 
when melittin (final concentration, 50 μM) was added to disrupt the cytoplasmic membrane of 
mast cells to determine the total amount of K+ in the cells.  
 
Fig. 3.  The dose-response graphs of K+ efflux (○), cell viability (●), hemolysis (×), and 
histamine release (▲) in (a) S. aureus cells, (b) erythrocytes, and (c) mast cells induced by 
HR1.  S. aureus cells were suspended in 100 mM choline chloride and 50 mM Mops−Tris 
(pH 7.2) at 5 × 109 cells/ml.  Human erythrocytes were suspended in 0.15 M NaCl and 5 
mM Hepes−NaOH (pH 7.4) at 1 × 108 cells/ml.  Mast cells were suspended in a K+-free 
buffer solution comprising 0.154 M NaCl, 0.9 mM CaCl2, 5.6 mM glucose, 0.01% bovine 
serum albumin, and 5 mM Hepes−NaOH (pH 7.4) at 8 × 105 cells/ml.  S. aureus cells and 
erythrocytes were incubated with HR1 at 37oC for 30 min.  The amounts of K+ and 
histamine released from mast cells were determined after cells were incubated with HR1 at 
20oC for 5 min. 
 28
 
Fig. 4.  Granuliberin R-induced K+ efflux, cell viability, hemolysis, and histamine release in 
(a) S. aureus cells, (b) erythrocytes, and (c) mast cells.  The symbols used are the same as 
those in Fig. 3. 
 
Fig. 5.  Compound 48/80-induced K+ efflux, cell viability, hemolysis, and histamine release 
in (a) S. aureus cells, (b) erythrocytes, and (c) mast cells.  The symbols used are the same as 
those in Fig. 3. 
 
Fig. 6.  Changes in the morphology of human erythrocytes.  (a) Intact cells.  Cells were 
incubated with (b) HR1 (50 μM), (c) Polistes mastoparan (100 μM), or (d) Vespula 
mastoparan (50 μM) at 37oC for 30 min. 
 
Fig. 7.  Changes in the morphology of human erythrocytes induced by compound 48 and its 
constituents.  Cells were incubated at 200 μg/ml with (a) monomer, (b) dimer, (c) trimer, or 
(d) compound 48/80 at 37oC for 30 min. 
 
Fig. 8.  Changes in a morphological index as a function of the concentration of compound 48 
and its constituents.  Erythrocytes were incubated with monomer (×), dimer (○), trimer (∆), 
or compound 48/80 (●) at 37oC for 30 min. 
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